Neurological Soft Signs and neuroleptics in schizophrenia. A comparative study between haloperidol, risperidone and clozapine treated patients;Neurological soft signs e trattamento neurolettico. Uno studio comparativo tra aloperidolo, risperidone e clozapina in pazienti schizofrenici

Rivista di Psichiatria

Volumn 37, Issue 2, 2002, Pages 81-86

  Gherardelli, Simona ^a   Bersani, Giuseppe ^a  

^a SAPIENZA UNIVERSITY OF ROME   (Italy)

Author keywords

Neurological Soft Signs Neurological Evaluation Scale; Schizophrenia; Typical and atypical neuroleptics

Indexed keywords

CLOZAPINE; HALOPERIDOL; NEUROLEPTIC AGENT; RISPERIDONE;

ANALYSIS OF VARIANCE; ARTICLE; DISEASE SEVERITY; HUMAN; INCIDENCE; MAJOR CLINICAL STUDY; MOTOR COORDINATION; NEUROLOGIC EXAMINATION; NEUROPSYCHOLOGY; SCHIZOPHRENIA; SCORING SYSTEM;

EID: 0036114399     PISSN: 00356484     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (41)

1. Significance and meaning of neurological soft signs in schizophrenia
2. The Neurological Evaluation Scale (NES): A structured instrument for assessment of neurological signs in schizophrenia
3. The Cambridge neurological inventory: A clinical instrument for assessment of soft neurological signs in psychiatric patients
4. Sensorimotor functions and cognitive disturbance in psychiatric patients
5. Neurological soft signs and psychopathology: Incidence in diagnostic group
6. Neurological soft signs and psychopathology: Findings in schizophrenia
7. Soft signs of neurological dysfunction in schizophrenia: An investigation of lateral performance
8. Neurological differences between paranoid and non paranoid schizophrenia: Neurological soft signs
9. Neurodevelopmental pathogenesis of schizophrenia
10. Effect of side and rate of stimulation on cerebral blood flow changes in motor areas during finger movements in humans
11. Sensorimotor cortex lateralization is anomalous in patients with schizophrenia: A whole brain fMRI study
12. Motor dysfunction and sensorimotor cortex activation changes in schizophrenia: A study with the functional magnetic resonance imaging
13. Consistency of non focal neurological signs
14. Domains of psychopathology relevant to the study of etiology and treatment of schizophrenia
15. Neurological soft signs in schizophrenia
16. Neurological soft signs in schizophrenia
17. Neurological signs, age and illness duration in schizophrenia
18. Neurological signs and the positive-negative dimension in schizophrenia
19. Soft signs and neuropsychological performance in schizophrenia
20. Neurocognitive deficits and neurological signs in schizophrenia
21. Schizophrenic syndromes, cognitive performance and neurological dysfunction
22. Neurological abnormalities in schizophrenic patients and their siblings
23. Are neurological abnormalities in schizophrenic patients and their siblings the result of perinatal trauma?
24. Neurologic abnormalities in schizophrenic patients and their, families: II neurologic and psychiatric findings in relatives
25. Hard neurologic signs and psychopatology in relatives of schizophrenic patients
26. Neurological dysfunctioning in offspring of schizophrenics in Israel and Denmark
27. Schizophrenia with good and poor outcome: Early clinical features response to neuroleptics and signs of organic disfuction
28. The clinical correlates of neurological soft signs in chronic schizophrenia
29. Schizophrenia and neurological soft signs: Gender differences in clinical correlates and antecedent factors
30. Neurological soft signs and response to risperidone in chronic schizophrenia
31. Memory deficits in subsyndromes of chronic schizophrenia
32. Relationship between neurological "soft signs" and syndromes of schizophrenia
33. Neurological and neuropsychological tests in schizophrenics
34. Stability of neurological signs with clozapine treatment
35. Neurological abnormalities in schizophrenic patients
36. Neurological examination abnormalities in neuroleptic-naive patients with first-break schizophrenia: Preliminary results
37. Premorbid adjustment as a predictor of phenomenological and neurobiological indices in schizophrenia
38. Stability of neurological soft signs in chronically hospitalized schizophrenic patients
39. Determinants of neurological dysfunction in first episode schizophrenia
40. Progressive deterioration of soft neurological signs in chronic schizophrenic patients